Is a Snapback Rally in the Works for This DLE Co?
Source: Clive Maund 07/16/2024
Technical Analyst Clive Maund shares an updated on Lithos Group Ltd. (LITS:CBOE.CA; LITSF:OTCMKTS; FSE:YU8; WKN:A3ES4Q) to explain why he believes it is an Immediate Strong Buy.
There has been quite a severe drop in Lithos Group Ltd. (LITS:CBOE.CA; LITSF:OTCMKTS; FSE:YU8; WKN:A3ES4Q) stock since we last looked at it for capital markets reasons, yet the fundamental reasons for owning the stock remain much the same, and despite the drop in price it has remained under accumulation as we will see and while this admittedly is little consolation if you are holding the stock it does greatly increase the chances of a powerful rebound.
A number of reasons for the drop have emerged, which include 15% of the stock coming out of escrow at the end of April, which was then dumped, and in addition, the analyst covering the stock at Beacon Securities quit, but the important point is that while these negative factors were in play those “in the know” continued to buy the stock which explains why the Accumulation line has continued to rise even as the price has dropped and the reasons that they have continued to buy even in the face of some heavy selling is that there is a range of powerful catalysts in play that should drive the stock much higher and probably sooner rather than later since some of them are set to impact very soon.
These include. . .
- The company is still in the running for a US$30 million DOE (US Department of Energy) grant, which the company applied for back in January that is expected to be announced shortly, meaning during the next few weeks. If awarded, this grant exceeds the capitalization of the company.
- The company is negotiating three multimillion-dollar pilots after spectacular lab results with three of the largest lithium brine producers in the Western hemisphere, two of which are in Chile and one in Argentina.
- The company is in line for a number of contracts worth CA$5 to CA$6 million.
- The company is expecting to get an independant stamp of approval or validation from a reputable engineering firm on the quality of its technology and its recovery rates.
A big technical reason for reviewing it again here, in addition to the unrelenting accumulation, is that it appears to be making the second low of a Double Bottom and to be ready to advance anew, and in fact, it is looking like a “coiled spring” here so the rebound could be dramatic, especially if there is significant positive news out of the company.
Before considering its latest chart, it is worth taking another look at what the company brings to the lithium extraction industry with its proprietary DEL technology, which eliminates the need for extraction ponds and greatly improves the production yield.
Following are some very illuminating slides lifted from the company’s investor deck.
Slide 7 shows the problem that Lithos’ pioneering technology does away with.
Slide 5 shows the company’s technology, which makes sustainable lithium production possible without the need for evaporation ponds.
Slide 9 shows the over 9-fold increase in demand for lithium by 2035.
Slide 16 shows the huge increase in production yield from brine projects afforded by the company’s proprietary DEL technology.
Turning now to the chart for Lithos, we can see on its latest 6-month chart that, having broken below its moving averages, it accelerated to the downside into what looks like a final low early in June. Then, after stabilizing and attempting to rally last month, it dipped back to mark out what looks like the second low of a Double Bottom early this month, with a prominent bullish “dragonfly doji” appearing on the chart about a week ago whose intraday low is believed to mark the low for the downtrend in force from the February peak.
What is truly remarkable about the action of recent months in Lithos is that, even though the price has continued relentlessly lower, its Accumulation line has continued to climb and make new highs, and while, as mentioned above, this is little consolation to holders of the stock, it is an indication of inner strength and suggests a strong possibility that a powerful “snapback rally” is in the works, and from the look of the chart this could happen soon, especially given that downside momentum as shown by the MACD indicator is steadily dropping out.
Holders of Lithos Group should, therefore, stay long and perhaps add to holdings, and the stock is rated an Immediate Strong Buy here. It is available to U.S. investors on the OTC market, where it trades in healthy volumes.
Lithos Group’s website.
Lithos Group Ltd. (LITS:CBOE.CA; LITSF:OTCMKTS; FSE:YU8; WKN:A3ES4Q) closed at CA$0.27, US$0175 on July 15, 2024.
Sign up for our FREE newsletter at: www.streetwisereports.com/get-news
Important Disclosures:
- Lithos Group Ltd. has a consulting relationship with an affiliate of Streetwise Reports, and pays a monthly consulting fee between US$8,000 and US$20,000.
- As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Lithos Group Ltd.
- Clive Maund: I determined which companies would be included in this article based on my research and understanding of the sector.
- Statements and opinions expressed are the opinions of the author and not of Streetwise Reports, Street Smart, or their officers. The author is wholly responsible for the accuracy of the statements. Streetwise Reports was not paid by the author to publish or syndicate this article. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Any disclosures from the author can be found below. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.
- This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.
For additional disclosures, please click here.
Clivemaund.com Disclosures
The quoted article represents the opinion and analysis of Mr. Maund, based on data available to him, at the time of writing. Mr. Maund’s opinions are his own, and are not a recommendation or an offer to buy or sell securities. As trading and investing in any financial markets may involve serious risk of loss, Mr. Maund recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction and do your own due diligence and research when making any kind of a transaction with financial ramifications. Although a qualified and experienced stock market analyst, Clive Maund is not a Registered Securities Advisor. Therefore Mr. Maund’s opinions on the market and stocks cannot be only be construed as a recommendation or solicitation to buy and sell securities.
( Companies Mentioned: LITS:CBOE.CA;LITSF:OTCMKTS;FSE:YU8;WKN:A3ES4Q, )
Source: https://www.streetwisereports.com/article/2024/07/16/is-a-snapback-rally-in-the-works-for-this-dle-co.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Lion’s Mane Mushroom Nootropic
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.
Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.
Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.
Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.
Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
![Report abuse](/img/report_abuse.png)